Double Voiding and Post-transplant UTI

ConditionsUrinary Tract Infections Kidney Transplant; Complications

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorWeill Medical College of Cornell University

About this trial

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.

Disqualifiers

Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)

Trial design

Design model

Parallel

Treatments tested in this trial

Double Voiding
Other intervention
Participant will be instructed to void twice.
Regular Voiding
Other intervention
Participant will void as usual

Treatment groups

438 Participants

are divided into 2 treatment groups

Group A: Double VoidingExperimental treatment 1 intervention

Group B: Regular VoidingActive comparator 1 intervention

Trial outcomes

Primary outcomes

Number of UTI's

UTI will be defined as a clean catch urine bacterial culture that is reported as anything other than "\<1000 CFU/ml (Colony Forming Unit / Milliliter)- Negative". Clean catch urine cultures are done at each follow-up visit as a standard of care, irrespective of patient symptoms. Hence the outcome will include both asymptomatic and symptomatic UTIs.

Time frame